Valuation Pressure BioSciences, Inc.
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
|
Market Closed -
OTC Markets
13:43:58 2026-03-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.000500 USD | -.--% |
|
+400.00% | - |
Company Valuation: Pressure BioSciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3.942 | 3 | 8.309 | 18.35 | 15.89 | 7.769 |
| Change | - | -23.9% | 177.01% | 120.88% | -13.44% | -51.1% |
| Enterprise Value (EV) 1 | 8.843 | 10.93 | 17.89 | 32.86 | 36.41 | 30.57 |
| Change | - | 23.54% | 63.72% | 83.73% | 10.8% | -16.03% |
| P/E | -0.15x | -0.16x | -0.4x | -0.68x | -0.81x | -0.22x |
| PBR | -0.62x | -0.26x | -0.52x | -0.95x | -0.54x | -0.36x |
| PEG | - | 0x | 0x | 0x | 0x | 0.03x |
| Capitalization / Revenue | 1.6x | 1.66x | 6.81x | 9.17x | 9.19x | 3.93x |
| EV / Revenue | 3.6x | 6.04x | 14.7x | 16.4x | 21.1x | 15.5x |
| EV / EBITDA | -2.02x | -1.92x | -4.01x | -8.06x | -7.62x | -3.26x |
| EV / EBIT | -1.98x | -1.88x | -3.9x | -7.85x | -7.43x | -3.22x |
| EV / FCF | -1.8x | -4.29x | -5.03x | -3.13x | -7.97x | -2.64x |
| FCF Yield | -55.6% | -23.3% | -19.9% | -32% | -12.6% | -37.9% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -15.33 | -7.984 | -5.322 | -3.418 | -1.61 | -1.508 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 2.458 | 1.81 | 1.221 | 2.002 | 1.729 | 1.978 |
| EBITDA 1 | -4.383 | -5.682 | -4.458 | -4.075 | -4.779 | -9.391 |
| EBIT 1 | -4.477 | -5.806 | -4.586 | -4.185 | -4.898 | -9.503 |
| Net income 1 | -9.699 | -11.66 | -16.01 | -20.15 | -16.08 | -29.31 |
| Net Debt 1 | 4.901 | 7.925 | 9.577 | 14.51 | 20.53 | 22.8 |
| Reference price 2 | 2.250000 | 1.250000 | 2.120000 | 2.310000 | 1.300000 | 0.330000 |
| Nbr of stocks (in thousands) | 1,752 | 2,400 | 3,919 | 7,945 | 12,221 | 23,543 |
| Announcement Date | 4/16/19 | 4/14/20 | 4/15/21 | 4/5/22 | 4/12/23 | 6/7/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 8.59K | |
| 32.37x | 5.68x | 21.76x | 0.28% | 241B | |
| 35.73x | 6.44x | 20.4x | 0.66% | 149B | |
| 42.63x | 11.26x | 24.86x | -.--% | 139B | |
| 16.35x | 3.36x | 10.93x | -.--% | 62.81B | |
| 34.88x | 6.99x | 22.11x | -.--% | 50.87B | |
| 18.76x | 2.27x | 11.4x | 2.71% | 48.21B | |
| 30.48x | 6.04x | 20.52x | 0.66% | 44.11B | |
| 73.82x | 7.03x | 21.43x | -.--% | 41.42B | |
| 48.45x | 7.8x | 27.53x | -.--% | 36.18B | |
| Average | 37.05x | 6.32x | 20.10x | 0.48% | 81.23B | |
| Weighted average by Cap. | 35.58x | 6.66x | 20.78x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PBIO Stock
- Valuation Pressure BioSciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
